Last reviewed · How we verify
tetanus-CMV fusion peptide vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
tetanus-CMV fusion peptide vaccine (tetanus-CMV fusion peptide vaccine) — City of Hope Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| tetanus-CMV fusion peptide vaccine TARGET | tetanus-CMV fusion peptide vaccine | City of Hope Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- tetanus-CMV fusion peptide vaccine CI watch — RSS
- tetanus-CMV fusion peptide vaccine CI watch — Atom
- tetanus-CMV fusion peptide vaccine CI watch — JSON
- tetanus-CMV fusion peptide vaccine alone — RSS
Cite this brief
Drug Landscape (2026). tetanus-CMV fusion peptide vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/tetanus-cmv-fusion-peptide-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab